VAX-D is a non-invasive treatment for the management of patients with chronic back and leg pain from lumbar disc and facet joint pathology (disease). VAX-D is an effective and safe procedure without any of the risks associated with surgery, injections, or anesthesia. Time off work or in recovery is minimal, and resolution of symptoms is longlasting.

Low back pain (LBP) has become one of the most significant medical and socioeconomic problems

in today’s world. The statistics on the magnitude of the problem are overwhelming and the number of chronic back cases continues to grow each day. In fact, low back pain that is related to work is the most common complaint presented to primary care physicians and workers compensation.

Medicine in the United States is widely regarded as the best in the world. Still, patient dissatisfaction with current treatments has rarely been more acute. Patients are becoming more educated about their own conditions, and they are seeking out non-invasive treatments such as VAX-D.

In the majority of patients, acute back pain symptoms resolve on their own in one to two months. Those that fail to resolve are then routinely referred to orthopedists or neurosurgeons.

Treating a patient with chronic low back pain can often be one of the most challenging situations for the physician.

Back pain is frequently treated in an episodic manner, with a multitude of treatments such as drugs, heat and cold, bed-rest, chiropractic/ manipulation, physical therapy, exercises, acupuncture, TENS, epidural injections, prolotherapy, IDET (Intradiscal Electrothermal Therapy or heat cauterization with an electrothermal catheter) and the various types of surgery.

Many of these are simply aimed at providing temporary reduction of symptoms without altering the underlying disease process or addressing the pathophysiology associated with lumbar discogenic disorders. Physicians are faced with the fact that there is no universally accepted algorithm for the care of such patients.

"Surgical decompression" of intervertebral discs has been established for the management of low back pain and sciatic pain in selected cases. Surgery may disrupt the natural biomechanical functions essential to preserve pain-free spinal mobility. The majority of LBP patients are not ideal surgical candidates, and surgery in the poorly selected patient can lead to ‘failed back syndrome’. Before resorting to a surgical approach, it makes sense to try a conservative procedure.

It is known that the many forms of ‘traction’ and gravity inversion have not demonstrated the ability to lower the intradiscal pressure. Clinical study has now documented VAX-D’s ability to lower intradiscal pressure (Ramos G., Martin W. Journal of Neurosurgery). Decompression of the discs and spinal structures is achieved under precisely controlled, monitored conditions with no disruption of the spines normal biomechanics.

VAX-D is the only medical device that delivers treatment with the patented logarithmic decompression curve.

VAX-D can relieve the pain associated with herniated discs, degenerative disc disease, posterior facet syndrome and radicular (nerve root/leg) pain. Now, specialists and primary care physicians can effectively manage acute and chronic low back problems conservatively and effectively in their own offices. Patients can avoid the costly and time consuming merry-go-round of drugs and non-specific treatments like bed-rest, physical therapy, injections, and others.

VAX-D clinics have been now been successfully operating for over ten years in the US, as well as in Canada, Puerto Rico, Mexico and Australia. More than 3000 patients a day now receive VAX-D therapy in the US. Studies on the efficacy from all of the independent sources (hospitals, private clinics, clinical studies) consistently report similar levels of success in the range of 70%.

VAX-D therapy has been used by the best professional sports figures including those in the NBA, NFL, NHL, Major League Baseball, Olympic athletes and many others. Public recognition and demand for access to VAX-D therapy, along with acceptance by primary care physicians and specialists is driving the expansion of VAX-D centers, and is compelling health insurance companies to consider VAX-D as the standard of care.

---- Select article ---- VAX-D Reduces Chronic Low Back Pain Effects of VAX-D on Sensory Nerve Dysfunction VAX-D for Low Back Pain Nerve root decompression after VAX-D Doctors Overly Optimistic About Surgery Return to Activity Helps Back Pain Surgery Often Won't Cure Back Pain People in Pain Often Suffer Silently Efficacy of vertebral axial decompression 2004 Prospective Randomised Controlled Study of VAX-D and TENS for the Treatment of Chronic Low Back Pain 2001 VAX-D Reduces Chronic Discogenic 2002 Vertebral Axial Decompression Therapy 2001 Prospective Randomized Study of VAX-D 2005 Nerve Root Decompression After VAX-D THERAPY 2003 An Overview of Vertebral Axial Decompression 1996 Effects Of Vertebral Axial Decompression 1994 The Effects Of Vertebral Axial Decompression On Sensory Nerve Dysfunction 1999 Welcome Relief for Low Back Pain 2004 SHORT AND LONG-TERM OUTCOMES using VAX-D 2005 LANDMARK STUDY CONFIRMS VAX-D THERAPY 2005